 |
市场调查报告书
商品编码
1427264
全球神经诊断市场规模、份额、成长分析（按病理、最终用户）- 2023-2030 年产业预测Global Neurodiagnostics Market Size, Share, Growth Analysis, By Condition(Neuro Degenerative Diseases, Epilepsy), By End User(Hospitals & Surgery Centers, Diagnostic Laboratories & Imaging Centers) - Industry Forecast 2023-2030 |
||||||
2022年全球神经诊断市场规模预计为74.5亿美元，从2023年的79.7亿美元增长到2031年的13.6亿美元，预测期内（2024-2031年）复合年增长率为7%。预计将增长至9000万美元。
神经诊断市场对于医疗保健专业人员诊断、监测和製定神经系统疾病的治疗计划至关重要。我们可以了解大脑和神经系统的功能、识别异常并制定适当的治疗策略。神经诊断程序包括各种测试，如脑电图 (EEG)、肌电图 (EMG)、神经影像技术（MRI、 电脑断层扫描）和专门评估，所有这些都可以提供神经系统状况的宝贵见解。神经诊断市场背后的驱动力是全球神经系统疾病数量的增加。阿兹海默症、癫痫和多发性硬化症等疾病正变得越来越常见，这凸显了对准确有效的诊断工具的需求。该市场面临的挑战包括神经系统疾病的复杂性，通常需要多种诊断方法才能进行准确评估。解释神经诊断测试的结果也很困难，需要专业知识和先进的资料分析技术。儘管面临挑战，神经诊断市场仍提供了巨大的机会。人工智慧 (AI) 和机器学习等技术进步是提高诊断准确性和效率的有希望的手段。远端医疗和远端监控功能的集合成为远端神经诊断铺平了道路，确保即使在服务不足的地区也能获得专门护理。最终，全球神经诊断市场透过促进神经系统疾病的诊断和监测来为医疗保健专业人员提供服务。儘管成本和监管等障碍仍然存在，但技术创新、远端监控和研究合作等机会正在促进市场的成长和加强。
使用自上而下和自下而上的方法，我们估计并检验了全球神经诊断市场规模，并估计了其他各个相关子市场的市场规模。用于估计市场规模的调查方法包括以下详细资讯：用于确定市场主要企业的二次研究，用于确定每个地区的市场占有率的主要和二次研究。整个过程包括研究主要企业的年度和财务报告以及广泛的采访，以获得执行长、副总裁、董事和行销负责人等行业领导者的重要见解。所有股份比率和细分均使用二手资讯确定并使用主要资讯检验。本研究涵盖的所有可能影响市场的参数都经过考虑、详细研究、经过初步研究检验，并进行分析以获得最终的定量和定性资料。
全球神经诊断市场細項分析
全球神经诊断市场根据病理、最终用户和地区进行细分。就病理而言，市场分为神经退化性疾病、癫痫、中风、头痛疾病、睡眠障碍等。依最终用户细分，市场分为医院和手术中心、诊断实验室和影像中心、神经学中心等。依地区划分，分为北美、欧洲、亚太地区、中东/非洲、拉丁美洲。
全球神经诊断市场的驱动因素
阿兹海默症、帕金森氏症和癫痫等神经系统疾病的上升趋势是推动神经诊断市场向前发展的关键因素。由于世界老化和生活方式的改变，神经系统疾病的发生率不断上升，导致对用于诊断和监测目的的精确神经诊断的需求增加。
脑电图设备、肌电图 (EMG) 设备和神经影像设备等神经诊断设备的进步继续推动市场扩张。这些技术进步增强了功能、提高了准确性并提高了患者的舒适度。此类先进设备的存在鼓励医疗保健提供者购买神经诊断设备，并刺激市场成长。
全球神经诊断设备市场的限制因素
与神经诊断程序相关的高成本可能会阻碍市场成长。这些手术通常需要昂贵的设备、专门的测试和熟练的医务人员。这些成本可能会限制获得这些治疗的机会，特别是在低收入和中等收入国家，并阻碍市场扩张。
神经诊断领域必须遵守严格的监管标准和合规通讯协定。新的神经诊断设备和技术获得监管部门的批准需要漫长而昂贵的努力。这些监管障碍可能会阻碍创新和新产品的推出，从而阻碍市场扩张。
全球神经诊断市场趋势
将资料分析和云端运算融入神经诊断中变得越来越普遍。在云端储存和分析大量患者资料可以简化资料管理、远端协作以及创建支援诊断和治疗策略的预测模型。这种转变鼓励在神经诊断中使用资料驱动的方法和个人化护理。
目录
- 执行摘要
- 调查方法
- 母市场分析
- 主要市场考察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- Start-Ups分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 主要投资分析
- 关键成功因素
- 竞争程度
- 市场动态及展望
- 市场动态
- 促进因素
- 机会
- 抑制因素
- 任务
- 监管形势
- 波特的分析
- 对未来中断的特殊考虑
- 市场动态
- 全球神经诊断市场：依病理状态分类
- 市场概况
- 神经退化性疾病
- 癫痫
- 中风
- 头痛症
- 睡眠失调
- 其他的
- 全球神经诊断市场：按最终用户划分
- 市场概况
- 医院及手术中心
- 诊断实验室和影像中心
- 神经中枢
- 其他的
- 全球神经诊断市场规模：按地区划分
- 市场概况
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区
- 竞争形势
- 前5名企业对比
- 主要企业市场定位（2021年）
- 主要市场参与者所采取的策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率（2021年）
- 主要企业简介
- Siemens Healthineers（Germany）
- GE Healthcare（US）
- Philips Healthcare（Netherlands）
- Medtronic（Ireland）
- Hitachi Medical Corporation（Japan）
- Natus Medical Incorporated（US）
- Abbott Laboratories（US）
- Koninklijke Philips NV（Netherlands）
- Thermo Fisher Scientific Inc.（US）
- Elekta AB（Sweden）
- Brainlab AG（Germany）
- Masimo Corporation（US）
- Cadwell Industries Inc.（US）
- Advanced Brain Monitoring, Inc.（US）
- Compumedics Limited（Australia）
- Neurosoft Ltd.（Russia）
- Magstim（UK）
- NeuroWave Systems Inc.（US）
- BrainScope Company Inc.（US）
- Blackrock Microsystems LLC（US）
Global Neurodiagnostics Market size was valued at USD 7.45 Billion in 2022 and is poised to grow from USD 7.97 Billion in 2023 to USD 13.69 Billion by 2031, at a CAGR of 7% during the forecast period (2024-2031).
The neurodiagnostics market is essential for aiding healthcare professionals in diagnosing, monitoring, and planning treatment for neurological disorders. It enables them to comprehend brain and nervous system functioning, identify irregularities, and devise appropriate treatment strategies. Neurodiagnostic procedures encompass various tests like electroencephalography (EEG), electromyography (EMG), neuroimaging techniques (MRI, CT scan), and specialized assessments, all providing valuable insights into neurological conditions. A driving force behind the neurodiagnostics market is the global increase in neurological disorder prevalence. Conditions like Alzheimer's disease, epilepsy, and multiple sclerosis are becoming more common, highlighting the necessity for precise and effective diagnostic tools. Challenges in this market include the intricate nature of neurological disorders, often requiring multiple diagnostic methods for accurate evaluations. Interpreting neurodiagnostic test results also poses difficulties, demanding specialized knowledge and advanced data analysis techniques. Despite challenges, the neurodiagnostics market offers substantial opportunities. Technological advancements such as artificial intelligence (AI) and machine learning hold promise for enhancing diagnostic accuracy and efficiency. Integration of telemedicine and remote monitoring capabilities creates avenues for remote neurodiagnostics, ensuring access to specialized care in underserved regions. Ultimately, the global neurodiagnostics market serves healthcare professionals by facilitating the diagnosis and monitoring of neurological disorders, driven by increasing disorder prevalence and the demand for precise diagnostic tools. While obstacles like costs and regulations persist, opportunities for technological innovations, remote monitoring, and research collaborations contribute to the market's growth and enhancement.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurodiagnostics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.
Global Neurodiagnostics Market Segmental Analysis
The global neurodiagnostics market is segmented on the basis of condition, end user, and region. In terms of condition, the market is segmented into neuro degenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and others. With respect to categorization by end user, the market is segmented into hospitals & surgery centres, diagnostic laboratories & imaging centres, neurology centres, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Neurodiagnostics Market
The increasing occurrence of neurological disorders like Alzheimer's disease, Parkinson's disease, and epilepsy is a significant factor propelling the neurodiagnostics market forward. With aging populations and shifts in lifestyles worldwide, the incidence of neurological disorders is on the rise, consequently escalating the need for precise neurodiagnostic procedures for diagnosis and monitoring purposes.
The ongoing progress in neurodiagnostic equipment, including EEG machines, electromyography (EMG) devices, and neuroimaging tools, is fuelling market expansion. These technological advancements offer enhanced features, increased precision, and improved patient comfort. The presence of these advanced devices encourages healthcare providers to procure neurodiagnostic equipment, thus stimulating market growth.
Restraints in the Global Neurodiagnostics Market
The substantial expenses linked with neurodiagnostic procedures may impede market growth. These procedures typically entail costly equipment, specialized examinations, and skilled medical personnel. Such expenses could restrict access to these procedures, particularly in low- and middle-income nations, thus obstructing market expansion.
The neurodiagnostics sector must adhere to strict regulatory standards and compliance protocols. Securing regulatory clearance for novel neurodiagnostic devices and methods can be a lengthy and costly endeavor. These regulatory obstacles may impede innovation and the introduction of new products, presenting obstacles to market expansion.
Market Trends of the Global Neurodiagnostics Market
The incorporation of data analytics and cloud computing into neurodiagnostics is becoming increasingly popular. Storing and analyzing extensive patient data in the cloud allows for streamlined data management, remote collaboration, and the creation of predictive models to enhance diagnosis and treatment strategies. This shift encourages the use of data-driven approaches and personalized care in neurodiagnostics.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Market Dynamics
- Global Neurodiagnostics Market by Condition
- Market Overview
- Neuro Degenerative Diseases
- Epilepsy
- Stroke
- Headache Disorders
- Sleep Disorders
- and Others
- Global Neurodiagnostics Market by End User
- Market Overview
- Hospitals & Surgery Centers
- Diagnostic Laboratories & Imaging Centers
- Neurology Centers
- and Others
- Global Neurodiagnostics Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi Medical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natus Medical Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Brainlab AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Masimo Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cadwell Industries Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Advanced Brain Monitoring, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Compumedics Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neurosoft Ltd. (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Magstim (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroWave Systems Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BrainScope Company Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Blackrock Microsystems LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers (Germany)
神经诊断与监测设备 - 全球市场考量、竞争格局、市场预测 (2030)
神经诊断市场报告：2030 年趋势、预测与竞争分析
神经诊断·监测设备的开发平台 - 开发阶段，市场区隔，地区和国家，法规途径，主要企业(2023年版)
2030 年神经诊断市场预测：按产品、最终用户按症状和地区进行全球分析
2024-2028年神经诊断的全球市场
全球神经诊断学市场 - 2023-2030年
神经诊断市场：按产品、适应症和最终用户划分 - 全球预测 2023-2030
神经诊断的全球市场
神经诊断市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)